Peptide Therapy
Recovery and performance assessment, with a peptide approach considered only after testing and only for people who are eligible.
A peptide approach is considered only after consultation and testing, and only for people who are eligible. Eligibility is decided by a doctor individually, and some medical conditions make this approach unsuitable outright.
Who this is for
The most common pattern is someone whose training is consistent but whose recovery has slowed. A heavy session that used to take two days to come back from now takes four. Small injuries keep returning in the same place. Performance has flattened even as volume went up.
- Training is consistent but recovery keeps slowing
- A heavy session that took two days to recover from now takes four
- Small injuries returning in the same place
- Performance flat even as volume went up
- After an injury or surgery, recovering more slowly than expected
How it runs
Before any options are discussed, the assessment looks at the things that most often explain this pattern without needing anything exotic.
- 01Training load against recoveryThis accounts for a large share of cases, so it is looked at first before anything else.
- 02Sleep, energy and proteinSleep in terms of quality and not just hours. Insufficient recovery often starts with energy and protein intake.
- 03Blood markers and body compositionIncluding iron, thyroid and metabolic markers. For a lot of people this finds something correctable without anything further, and that is a good result.
- 04If the pattern persists after the basicsThe doctor discusses the options based on those findings, covering what the evidence shows and what it does not, regulatory status, known risks, what would be monitored, and the option of not going ahead. That discussion happens privately in consultation.
Swipe to see all steps
Limits and who this does not suit
Some conditions make this approach unsuitable outright. These include active cancer or a history of certain cancers, pregnancy and breastfeeding, some endocrine conditions, and active liver or kidney disease.
- Active cancer or a history of certain cancers
- Pregnancy and breastfeeding
- Some endocrine conditions
- Active liver or kidney disease
- This list is not complete. Eligibility is decided individually after a full assessment
- We do not claim this approach slows ageing or produces results that last once it stops
- This page does not advertise any product or medicine, lists no substances, and is not a treatment recommendation for anyone
Common questions
Why does this page not name anything?
Because advertising prescription medicines to the public is not permitted in Malaysia. Discussion of specific options happens in consultation, between you and the doctor.
Do I need testing first?
Yes. Without baseline values there is no way to decide eligibility or to judge whether anything is making a difference.
What if the assessment finds I am not suitable?
We will say so and talk through what else can be done for the pattern you came in with. The assessment still gives you useful information.
What is assessed before peptide therapy is considered?
A doctor assessment and metabolic assessment come first. Product registration status in Malaysia can be checked through NPRA. Book a consultation for an assessment. The wider pathway sits at performance and recovery.
Every iLIV guide is written and reviewed under our editorial standards, and each one carries the name of the reviewing doctor together with their MMC registration number.
Treatments on the same pathway
Not all of these suit everyone. The doctor assesses first.
Start with one conversation
An initial consultation to understand your situation before any testing is recommended.
Damansara Perdana · I-City, Shah Alam · +60 14-801 6493